Literature DB >> 2585400

Pulmonary arterial histology and morphometry in systemic sclerosis: a case-control autopsy study.

M R al-Sabbagh1, V D Steen, B C Zee, M Nalesnik, D C Trostle, C D Bedetti, T A Medsger.   

Abstract

Morphometric measurements were performed on pulmonary arteries in 58 patients with systemic sclerosis (20 limited cutaneous and 38 diffuse cutaneous involvement [21 with and 17 without renal crisis]) and age, race, and sex matched autopsy controls. Matched pairs analysis was employed. For arteries of all sizes, the area of the intima and percent luminal occlusion were greater in the limited and diffuse (no renal crisis) groups than in controls, and these differences were statistically significant for large and medium sized vessels. The greatest luminal occlusion was found in limited cutaneous patients, and especially those with clinical evidence of pulmonary arterial hypertension, providing a rationale for the poor response to vasodilator therapy in these patients.

Entities:  

Mesh:

Year:  1989        PMID: 2585400

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  12 in total

1.  Impact of the revised haemodynamic definition on the diagnosis of pulmonary hypertension in patients with systemic sclerosis.

Authors:  Sara Jaafar; Scott Visovatti; Amber Young; Suiyuan Huang; Paul Cronin; Dharshan Vummidi; Vallerie McLaughlin; Dinesh Khanna
Journal:  Eur Respir J       Date:  2019-08-22       Impact factor: 16.671

Review 2.  Scleroderma lung disease.

Authors:  Joshua J Solomon; Amy L Olson; Aryeh Fischer; Todd Bull; Kevin K Brown; Ganesh Raghu
Journal:  Eur Respir Rev       Date:  2013-03-01

Review 3.  Pulmonary hypertension in rheumatic diseases: epidemiology and pathogenesis.

Authors:  Anupama Shahane
Journal:  Rheumatol Int       Date:  2013-01-19       Impact factor: 2.631

Review 4.  Clinical aspects of systemic sclerosis (scleroderma).

Authors:  R M Silver
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

Review 5.  Treatment of systemic sclerosis.

Authors:  T A Medsger
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

6.  Computer based quantitative analysis of capillary abnormalities in systemic sclerosis and its relation to plasma concentration of von Willebrand factor.

Authors:  A Scheja; A Akesson; I Niewierowicz; L Wallin; M Wildt; F A Wollheim
Journal:  Ann Rheum Dis       Date:  1996-01       Impact factor: 19.103

7.  Scleroderma lung disease.

Authors:  Jérôme Le Pavec; David Launay; Stephen C Mathai; Paul M Hassoun; Marc Humbert
Journal:  Clin Rev Allergy Immunol       Date:  2011-04       Impact factor: 8.667

Review 8.  Vascular disease in scleroderma.

Authors:  Fredrick M Wigley
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

9.  Isolated DLco/VA reduction in systemic sclerosis patients: a new patient subset?

Authors:  Patricia Corzo; Anna Pros; Juana Martinez-Llorens; Luis Molina; Stephanie Fenxi Ling; Eva Balcells
Journal:  Clin Rheumatol       Date:  2018-10-27       Impact factor: 2.980

Review 10.  Mechanisms in the loss of capillaries in systemic sclerosis: angiogenesis versus vasculogenesis.

Authors:  Mirko Manetti; Serena Guiducci; Lidia Ibba-Manneschi; Marco Matucci-Cerinic
Journal:  J Cell Mol Med       Date:  2010-01-30       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.